BioSpace News Archive

INOVIO announced that Jacqueline Shea, Ph.D., President and CEO, will present at the 2023 RBC Capital Markets Global Healthcare Conference.

MindBio Therapeutics Corp. is pleased to announce that its common shares have listed on the Canadian Securities Exchange under the ticker MBIO.

Amylyx Pharmaceuticals, Inc. will report its first quarter 2023 financial results on Thursday, May 11, 2023, following the close of the U.S. financial markets.

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced it will release its first quarter 2023 results on Thursday, May 11, 2023, after the market close.

Nexus Pharmaceuticals, Inc. announced that its pharmaceutical manufacturing facility in Pleasant Prairie, Wisconsin, was successfully inspected by the Food and Drug Administration, which will allow Nexus to begin commercial operations.

Rhythm Pharmaceuticals, Inc. today announced that on May 2, 2023, the Compensation Committee of Rhythm’s board of directors granted inducement equity grants covering an aggregate of 76,440 shares of its common stock to 16 new employees.

Chinook Therapeutics, Inc. today announced upcoming data presentations at the 60th ERA Congress from June 15 – 18, 2023, both virtual and live in Milan, Italy.

Pardes Biosciences, Inc. (NASDAQ: PRDS) today reported financial results for the first quarter ended March 31, 2023.

Mirati Therapeutics, Inc. today announced that the company granted equity awards to 2 new employees with a grant date of May 1, 2023, as equity inducement awards outside of the company’s 2022 Equity Incentive Plan (but under the terms of the company’s Inducement Plan) and material to the employees’ acceptance of employment with the company.

Mereo BioPharma Group plc today announced that it has received approval from Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) to transfer the listing of its American Depositary Shares (“ADSs”) from the Nasdaq Global Market to the Nasdaq Capital Market.